Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 73 - 80 of 12091 results

DOJ Sends Warning in Gender Care Provider Subpoenas
July 11, 2025| News

The One Big Beautiful Bill Act Signed into Law: Tax Implications at a Glance
July 10, 2025| Alert| Viewpoint

QSBS Benefits Expanded Under One Big Beautiful Bill Act
July 10, 2025| Alert| Viewpoint

LPs Question GPs on Rise of Semi-liquids and Potential Conflicts with Funds
July 10, 2025| News

FDA in Flux — July 2025 Newsletter
July 9, 2025| Article| Viewpoint

Best Practices for Communicating with the FDA
July 9, 2025| Podcast| Viewpoint

Federal Court Temporarily Halts Iowa’s PBM Reform Law Amid Legal Challenges
July 8, 2025| Blog| Viewpoint

Health Care Fraud Enforcement Developments: the 2025 Takedown and a “New” False Claims Act Working Group
July 7, 2025| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
